Indications for Rituximab Use in an Integrated Health Care Delivery System

BACKGROUND: Rituximab is a top-selling biologic that was first approved by the FDA in 1997 for a non-Hodgkin lymphoma orphan indication. It has since been approved for additional orphan indications, with rheumatoid arthritis as the only FDA-approved, nonorphan indication. Evidence suggests that ritu...

Descripción completa

Detalles Bibliográficos
Autores principales: Delate, Thomas, Hansen, Margaret L., Gutierrez, Amarylis C., Le, Kim N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391100/
https://www.ncbi.nlm.nih.gov/pubmed/32584674
http://dx.doi.org/10.18553/jmcp.2020.26.7.832

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391100/
https://www.ncbi.nlm.nih.gov/pubmed/32584674
http://dx.doi.org/10.18553/jmcp.2020.26.7.832

Ejemplares similares